JPS63275509A - Film-forming pack agent of two-part reaction type - Google Patents
Film-forming pack agent of two-part reaction typeInfo
- Publication number
- JPS63275509A JPS63275509A JP11154487A JP11154487A JPS63275509A JP S63275509 A JPS63275509 A JP S63275509A JP 11154487 A JP11154487 A JP 11154487A JP 11154487 A JP11154487 A JP 11154487A JP S63275509 A JPS63275509 A JP S63275509A
- Authority
- JP
- Japan
- Prior art keywords
- agent
- film
- pack
- carrageenan
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000006757 chemical reactions by type Methods 0.000 title abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 71
- 239000000679 carrageenan Substances 0.000 claims abstract description 22
- 229920001525 carrageenan Polymers 0.000 claims abstract description 22
- 229940113118 carrageenan Drugs 0.000 claims abstract description 22
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 18
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 18
- 239000007864 aqueous solution Substances 0.000 claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 11
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims abstract description 4
- 229910021645 metal ion Inorganic materials 0.000 claims description 9
- -1 ammonium ions Chemical class 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 7
- 150000002500 ions Chemical class 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 230000007794 irritation Effects 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 3
- 150000001455 metallic ions Chemical class 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000001879 gelation Methods 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 230000003625 amylolytic effect Effects 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical group O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 108010038061 Chymotrypsinogen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は二液反応性の皮膜形成型パック剤に関し、詳し
くは使用時に十分な膜形成機部を発揮する二液反応性の
皮膜形成型パック剤に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a two-component reactive film-forming pack agent, and more specifically, a two-component reactive film-forming pack agent that exhibits a sufficient film-forming unit during use. Regarding pack agents.
[従来の技術]
従来のパック剤は、使用上から、皮膜形成型のものと、
ふき取り又は洗い流し型のものに分けられ1本発明は前
者の皮膜形成型のパック剤に存する特有の課題を解決す
る技術である。[Prior art] Conventional pack agents are of a film-forming type,
There are two types: wipe-off and wash-off type packs, and the present invention is a technology to solve the problems unique to the former type of film-forming packs.
従来、皮膜形成型のパック剤に関する技術は、特開昭6
l−17SOfi号、同61−268611号、同62
−4216号に記載されたものが知られている。Conventionally, the technology related to film-forming pack agents was disclosed in Japanese Patent Application Laid-Open No. 6
l-17SOfi No. 61-268611, No. 62
The one described in No.-4216 is known.
[発明が解決しようとする問題点]
特開昭61−17506号に記載のパック剤は、皮膜形
成剤として、カラギーナンやポリビニルアルコール等の
水溶性高分子を用いている。ポリビニルアルコールを用
いた場合には、皮膜強度はあるが乾燥速度が遅く、皮膜
剥離時に皮膚を刺激する欠点がある。またカラギーナン
単独の場合には、皮膜強度が弱く、皮膜乾燥速度が遅い
欠点かあり、カオリンと併用すると、カオリン中のアル
カリ成分と反応してバックする前にゲル化してしまい、
実際に使用できない欠点がある。[Problems to be Solved by the Invention] The pack agent described in JP-A-61-17506 uses a water-soluble polymer such as carrageenan or polyvinyl alcohol as a film forming agent. When polyvinyl alcohol is used, although the film has strength, it has a slow drying rate and has the disadvantage of irritating the skin when the film is peeled off. Furthermore, when using carrageenan alone, the film strength is weak and the film drying speed is slow, and when used in combination with kaolin, it reacts with the alkaline component in the kaolin and gels before it backs up.
There are drawbacks that make it unusable.
また特開昭61−268611号及び同[12−421
6号に記載のパック剤はいずれもポリビニルアルコール
を皮膜剤としているため、乾燥速度が遅く皮膜剥離時に
皮Gを刺激する欠点かあり、また上記両パック剤におい
てカラギーナンが用いられているが膜形1& ikを利
用した技術ではない。Also, JP-A-61-268611 and JP-A No. 12-421
Since all of the packs described in No. 6 use polyvinyl alcohol as a film agent, they have the disadvantage of slow drying speed and irritation of the skin when the film is peeled off.Also, carrageenan is used in both of the packs mentioned above, but the film form is It is not a technology that uses 1 & ik.
[発明の目的]
そこで、本発明の目的は乾爆速度が速く、皮膜強度か強
く、かつ使用時に十分な膜形I&機箋を発揮する二液反
応性の皮膜形成型パック剤を提供することを目的とする
。[Object of the Invention] Therefore, the object of the present invention is to provide a two-component reactive film-forming pack agent that has a fast drying speed, strong film strength, and exhibits sufficient film form I and texture during use. With the goal.
[問題点を解決するための手段]
本発明者は、鋭意検討の結果、本発明を完成するに至っ
たものであり、本発明に係る二液反応性の皮膜形成型バ
ック剤はカラギーナンの水溶液とタンパク質との混合物
を第一剤とし、該第一剤と反応しうる一価又は二価の金
属イオン若しくはアンモニウムイオンを含有する水溶液
を第二剤とし、該第一剤と第二剤を用時に混合すること
を特徴とする。[Means for Solving the Problems] The present inventor has completed the present invention as a result of intensive studies, and the two-component reactive film-forming backing agent according to the present invention is an aqueous solution of carrageenan. The first agent is a mixture of and protein, the second agent is an aqueous solution containing a monovalent or divalent metal ion or ammonium ion that can react with the first agent, and the first agent and the second agent are used. It is characterized by sometimes being mixed.
[作用]
本発明のパック剤は、二液反応型のパック剤であるため
、使用したい時に十分な膜形成ず侶を発揮させることが
でき、また水溶性天然多糖類の中てもカラギーナンとタ
ンパク質の混合物と一価又は二価の全屈イオン若しくは
N11.″の水溶液が良好なゲル化反応を示し優れた皮
膜形成能(形成時間、低刺激性)を有することを利用し
た技術である。[Function] Since the pack agent of the present invention is a two-component reaction type pack agent, it can exhibit sufficient film-forming ability when desired to use, and also contains carrageenan and protein among water-soluble natural polysaccharides. A mixture of monovalent or divalent total ions or N11. This technology takes advantage of the fact that the aqueous solution of '' exhibits a good gelation reaction and has excellent film-forming ability (formation time, low irritation).
なお特開昭61−15813号のパック剤は、洗い流し
型のものであるが、水溶性天然多糖類とタンパク質と水
相成分とからなる。The pack agent disclosed in JP-A-61-15813 is of a wash-off type and is composed of a water-soluble natural polysaccharide, protein, and an aqueous phase component.
しかしこのパック剤は、二液反応型に用いることは不可
俤であり、また多糖類の中でカラギーナンのみが特別優
れた皮膜性を有することについては全く開示していない
。However, this pack agent cannot be used in a two-component reaction type, and there is no disclosure at all that among polysaccharides, only carrageenan has particularly excellent film properties.
[具体内構11i1 以下、本発明について詳説する。[Gutai internal structure 11i1 The present invention will be explained in detail below.
本発明に用いられる第一剤は、カラギーナンの水溶液と
タンパク質とを主成分とする混合物である。The first agent used in the present invention is a mixture whose main components are an aqueous solution of carrageenan and protein.
本発明に用いられるカラギーナンは、例えば紅そう類か
ら抽出し精製した炭水化物てあり、カッパ(に)−カラ
ギーナン、ラムダ(λ)−カラギーナン等のいずれを用
いることもでき、いずれを用いるかは、後述する第二剤
のイオン種との関係で好適なものを選択使用できる0例
えばに−カラギーナンの場合には、第二剤としてに0イ
オンが好ましいゲル化部を与え、またイオータ−(&)
−カラギーナン(に−カラギーナンより硫酸基が多いも
の)は、(: a * 0との間で特異的にCa”◆−
架橋や分子鎖間Ca 2 *−架橋を形成し好ましいゲ
ル化能を与える。The carrageenan used in the present invention is, for example, a carbohydrate extracted and purified from red soybean, and any of kappa (ni)-carrageenan, lambda (λ)-carrageenan, etc. can be used, and which one to use will be described later. For example, in the case of ni-carrageenan, the 0 ion gives a preferable gelling part as the second agent, and also the iota(&)
-Carrageenan (which has more sulfate groups than carrageenan) has a specific Ca”◆-
It forms crosslinks and intramolecular Ca 2 *-crosslinks and provides favorable gelling ability.
カラギーナンの添加量は第一剤全最に対し0.1〜10
wt%が好ましく、より好ましくは0.5〜5wt%で
ある。 0.1wt%未満ではゲル化力が弱く皮膜形
成が悪く、また10wt%を越える添加量としても効果
の向上は見られない。The amount of carrageenan added is 0.1 to 10 to the total amount of the first agent.
It is preferably 0.5 to 5 wt%, more preferably 0.5 to 5 wt%. If the amount is less than 0.1 wt%, the gelling power will be weak and film formation will be poor, and if the amount added exceeds 10 wt%, no improvement in the effect will be observed.
タンパク質としては、例えば加水分解エラスチン、水溶
性コラーゲン、カゼイン、大豆カゼイン、卵白アルブミ
ン、血清アルブミン、リゾチーム、大豆蛋白、小麦蛋白
、ホエー粉末、ケラチン、ゼラチン、水、アミラーゼ、
ペプシン、エノラーゼ、キモトリプシノーゲン等の中か
ら1種又は2種以上を選択使用できるが、中でも加水分
解エラスチン及び水溶性コラーゲンが好ましい。Examples of proteins include hydrolyzed elastin, water-soluble collagen, casein, soybean casein, ovalbumin, serum albumin, lysozyme, soybean protein, wheat protein, whey powder, keratin, gelatin, water, amylase,
One or more of pepsin, enolase, chymotrypsinogen, etc. can be selected and used, and among them, hydrolyzed elastin and water-soluble collagen are preferred.
タンパク質の添加量は、第一剤全量に対し、0.1〜6
0wt%が好ましい。The amount of protein added is 0.1-6 based on the total amount of the first agent.
0 wt% is preferred.
本発明の第一剤には、上記以外の添加物を含有すること
ができ、例えばエチレングリコール、プロピレングリコ
ール、1.3−ブチレンジグリコール、グリセリン、ジ
プロピレングリコール、ポリアルキレンゲリコール、ジ
グリセリン、トリグリセリン、ポリグリセリン、グルコ
ース、マルトース、マルチトール、マンニトール、ショ
糖、フラクトース、ソルビトール、キシリトール、ハチ
ミツ、マルトトリオース、エリスリトール、デンプン分
解糖、デンプン分解糖還元アルコール、dl−ピロリド
ンカルボン酸、旧−ピロリドンカルボン酸ナトリウム、
乳酸ナトリウム、アミノ酸、アミノ酸塩、化粧用アルコ
ール、水(精製水)などを含有することかできる。また
上記以外に皮Gへの効能効果を有する成分、湿潤剤、防
腐剤、香料などを含有せしめてもよい。The first agent of the present invention may contain additives other than those mentioned above, such as ethylene glycol, propylene glycol, 1,3-butylene diglycol, glycerin, dipropylene glycol, polyalkylene gellicol, diglycerin, Triglycerin, polyglycerin, glucose, maltose, maltitol, mannitol, sucrose, fructose, sorbitol, xylitol, honey, maltotriose, erythritol, amylolytic sugar, amylolytic sugar reduced alcohol, dl-pyrrolidonecarboxylic acid, old- Sodium pyrrolidone carboxylate,
It can contain sodium lactate, amino acids, amino acid salts, cosmetic alcohol, water (purified water), etc. In addition to the above, components having efficacy effects on skin G, humectants, preservatives, fragrances, etc. may be contained.
本発明に用いられる第二剤は一価又二価の金属イオン若
しくはアンモニウムイオン(N114’″)を含有する
水溶液を主成分とする。The second agent used in the present invention is mainly composed of an aqueous solution containing monovalent or divalent metal ions or ammonium ions (N114''').
一価又は二価の金属イオンは、好ましくはNib。The monovalent or divalent metal ion is preferably Nib.
K 4 、 Ca 2 h 、 S r t * 、
B a 2◆から選ばれる少なくとも一種であるが、い
かなるイオン種が好ましいかは、前述した如く第一剤の
カラギーナンのタイプによって選択することができる。K 4 , Ca 2 h , S r t *,
At least one kind selected from B a 2♦ is selected, and which ion species is preferable can be selected depending on the type of carrageenan in the first agent, as described above.
一価又は二価の金属イオンは、一価又は二価の金属の塩
又は水酸化物、水素化物、酸化物等の形で水溶液中に添
加されてイオンとして存在していればよく、この場合イ
オンは完全にイオン化されている必要はない。The monovalent or divalent metal ion only needs to be added to the aqueous solution in the form of a monovalent or divalent metal salt, hydroxide, hydride, oxide, etc., and exist as an ion. The ions do not need to be completely ionized.
N114’″は、通常アンモニア水の形で添加されるが
、各種アンモニウム塩(例えば塩化アンモニウム等)と
して添加されてもよい。N114''' is usually added in the form of aqueous ammonia, but may also be added in the form of various ammonium salts (for example, ammonium chloride, etc.).
一価又は二価の金属イオン若しくはアンモニウムイオン
の添加量は、第二剤総量に対し0.1〜8wt%が好ま
しく、より好ましくは1〜5%である。The amount of monovalent or divalent metal ion or ammonium ion added is preferably 0.1 to 8 wt%, more preferably 1 to 5%, based on the total amount of the second agent.
第二剤には上記以外に、水性防腐剤、水(精製水)か含
有されることが好ましい。In addition to the above, the second agent preferably contains an aqueous preservative and water (purified water).
以上の第一剤及び第二剤は各々プラスチック等の容器に
充填されていることが好ましく、また第二剤は圧力容器
に圧縮充填されていることも好ましい。It is preferable that the above-mentioned first agent and second agent are each filled in a container made of plastic or the like, and it is also preferable that the second agent is compressed and filled into a pressure container.
本発明においてr用時混合」とは、パック剤を皮膚(顔
)に塗る際に第一剤と第二剤を混合して使用することを
意味し、第一剤と第二剤とが別々に製造され、使用に際
して皮右上で混合することが好ましい。In the present invention, "mixing at the time of use" means that the first and second agents are mixed and used when applying the pack agent to the skin (face), and the first and second agents are separated. It is preferable to mix it in the upper right corner of the skin before use.
本発明のパック剤の使用方法は、第一剤を皮膚表面に塗
布しく通常手で塗り付ける)、次いで第二剤を皮膚表面
に噴霧し、両者の反応(ゲル化反応)によって皮膜形成
後、10〜20分経てから剥離する。The method of using the pack agent of the present invention is to apply the first agent onto the skin surface (usually by hand), then spray the second agent onto the skin surface, form a film by reaction between the two (gelling reaction), and then apply it for 10 minutes. Peel off after ~20 minutes.
尚、本発明のパック剤は顔以外に用いても構わない。Note that the pack agent of the present invention may be used on areas other than the face.
[実施例]
以下、本発明の詳細な説明するが、これらに限定される
訳ではない。[Example] The present invention will be described in detail below, but is not limited thereto.
実施例1
第一剤の製法
下記A成分を均一になるまで80°Cに加熱混合攪拌し
、40℃まで冷却した後、B成分を加え、混合攪拌し、
常温になるまで冷却して第一剤を得、これを容器に充填
した。Example 1 Manufacturing method of the first part Component A below was mixed and stirred at 80°C until uniform, cooled to 40°C, then component B was added, mixed and stirred,
The mixture was cooled to room temperature to obtain a first agent, which was filled into a container.
[へ成分]
カラギーナン 2wt%グリセリン
10 wt%精製水
60 wt%水性防腐剤 適
量
[B成分]
加水分解エラスチン(4%) 25wt%精製水
残量
第二剤の製法
下記成分を常温で均一になるまで攪拌して第二剤を得、
これを圧縮して圧力容器に充填した。[Ingredients] Carrageenan 2wt% glycerin
10 wt% purified water
60 wt% aqueous preservative appropriate amount [Component B] Hydrolyzed elastin (4%) 25 wt% purified water
How to make the remaining second part: Stir the following ingredients at room temperature until uniform to obtain the second part.
This was compressed and filled into a pressure vessel.
[成分]
塩化カリウム 4 wt%水性防腐剤
適量
精製水 残量
以上のようにして製造した第一剤を顔に塗布し、次いで
第二剤をその上からIIfl霧した。第一剤と第二剤は
ゲル化反応を起し、皮膜が形成された。[Ingredients] Potassium chloride 4 wt% aqueous preservative Appropriate amount of purified water Remaining amount The first agent prepared as described above was applied to the face, and then the second agent was sprayed onto the face. The first and second agents caused a gelation reaction and a film was formed.
皮膜形成時間は、5〜10分で、ソフトな皮膜で皮膚を
刺激しにくく、剥離後に皮膜に残るタンパク賀によって
肌をしっとりとなめらかにするものであった。The film formation time was 5 to 10 minutes, and the film was soft and did not irritate the skin, and the protein remaining in the film after peeling made the skin moist and smooth.
実施例2
実施例1において用いた第二剤の塩化カリウムをNaC
Jl 、 NH4Cl 、CaC文2.5rC12,B
aC1*に各々代えて同様のゲル化反応を行ったところ
、実施例1より皮膜形成時間が多少多く、また皮膜強度
もやや劣ったか、十分実用に供しうる程度であった。Example 2 The second agent potassium chloride used in Example 1 was replaced with NaC
Jl, NH4Cl, CaC sentence 2.5rC12,B
When a similar gelation reaction was carried out in place of aC1*, the film formation time was somewhat longer than in Example 1, and the film strength was also slightly inferior, or at a level sufficient for practical use.
比較例1
実施例1において、第一剤と第二剤に分離せずに、すべ
ての成分を混合してパック剤を得ようとしたら、製造過
程でゲル化を起し、実用に供し得なかった。Comparative Example 1 In Example 1, if an attempt was made to obtain a pack agent by mixing all the components without separating them into the first and second agents, gelation would occur during the manufacturing process and the pack could not be put to practical use. Ta.
比較例2
実施例1の第一剤中のカラギーナンをアルギン酸塩に代
え、かつ第二剤の塩化カリウムをCaC文2に代えた所
、タンパク質のゲル化能がなく、皮膜効果も不十分てあ
った。Comparative Example 2 When the carrageenan in the first part of Example 1 was replaced with alginate and the potassium chloride in the second part was replaced with CaC 2, there was no protein gelling ability and the film effect was insufficient. Ta.
[発明の効果]
本発明によれば、二液反応型のパック剤であるため、使
用したい時に、十分な膜形成能を発揮させることができ
、また水溶性天然多糖類の中でもカラギーナンとタンパ
ク質の混合物と一価又は二価の金属イオン若しくはNl
I4”の水溶液か良好なゲル化反応を示し優れた皮膜形
成部(形成時間、低刺激性)を有するパック剤を提供で
きる効果を有する。[Effects of the Invention] According to the present invention, since it is a two-component reaction type pack agent, it can exhibit sufficient film-forming ability when it is desired to be used. mixture and monovalent or divalent metal ion or Nl
The aqueous solution of I4'' exhibits a good gelation reaction and has the effect of providing a pack having an excellent film forming area (formation time, low irritation).
Claims (3)
第一剤とし、該第一剤と反応しうる一価又は二価の金属
イオン若しくはアンモニウムイオンを含有する水溶液を
第二剤とし、該第一剤と第二剤を用時に混合する二液反
応性の皮膜形成型パック剤。(1) A mixture of an aqueous carrageenan solution and protein is used as a first agent, an aqueous solution containing a monovalent or divalent metal ion or ammonium ion that can react with the first agent is used as a second agent, and the first agent is an aqueous solution containing monovalent or divalent metal ions or ammonium ions that can react with the first agent. A two-component reactive film-forming pack agent that mixes a second agent and a second agent at the time of use.
、Ca^2^+、Sr^2^+、Ba^2^+から選ば
れる少なくとも一種であることを特徴とする特許請求の
範囲第1項記載の二液反応性の皮膜形成型パック剤。(2) Monovalent or divalent metal ions are Na^+, K^+
, Ca^2^+, Sr^2^+, Ba^2^+, and Ba^2^+.
0.5〜5wt%であることを特徴とする特許請求の範
囲第1項又は第2項記載の二液反応性の皮膜形成型パッ
ク剤。(3) The two-component reactive film-forming type according to claim 1 or 2, wherein the content of the carrageenan aqueous solution is 0.5 to 5 wt% of the total amount of the first agent. pack agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11154487A JPS63275509A (en) | 1987-05-06 | 1987-05-06 | Film-forming pack agent of two-part reaction type |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11154487A JPS63275509A (en) | 1987-05-06 | 1987-05-06 | Film-forming pack agent of two-part reaction type |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63275509A true JPS63275509A (en) | 1988-11-14 |
JPH0211562B2 JPH0211562B2 (en) | 1990-03-14 |
Family
ID=14564064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11154487A Granted JPS63275509A (en) | 1987-05-06 | 1987-05-06 | Film-forming pack agent of two-part reaction type |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63275509A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2264058B (en) * | 1990-10-25 | 1994-08-10 | Narhex Ltd | Anti-wrinkle compositions comprising low molecular weight elastin |
-
1987
- 1987-05-06 JP JP11154487A patent/JPS63275509A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2264058B (en) * | 1990-10-25 | 1994-08-10 | Narhex Ltd | Anti-wrinkle compositions comprising low molecular weight elastin |
Also Published As
Publication number | Publication date |
---|---|
JPH0211562B2 (en) | 1990-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4474749A (en) | Anticariogenetic chewing gum | |
TWI327474B (en) | Kit for preparation of carbon dioxide agent for external use. | |
EP0045493A2 (en) | Composition useful for preparing face masks and process preparing such composition | |
CN109908025A (en) | Application of the glycine betaine in protection lysozyme activity | |
JPS58210006A (en) | Intermediate rinse for cold permanent wave setting | |
JPH0739333B2 (en) | Effervescent cosmetic and method of using the same | |
KR102181770B1 (en) | Cosmetic composition for skin peeling by producing carbon dioxide | |
JPH0421620A (en) | Two-part type pack cosmetic | |
JPS63275509A (en) | Film-forming pack agent of two-part reaction type | |
JPS5839608A (en) | Pack cosmetic | |
KR20080027758A (en) | Method of massaging skin having enhanced convenience | |
JPH06172141A (en) | Permanent wave agent and control of permanent wave | |
JP2840954B2 (en) | Adjustable cosmetics for use | |
JP2502414B2 (en) | Hair treatment composition | |
JPH0521081B2 (en) | ||
JPS5726612A (en) | Preparation of oral composition | |
JP3668508B2 (en) | Agents and methods for permanent processing of hair | |
JPS6030649B2 (en) | powder pack agent | |
JPS63201109A (en) | Reel-off type pack cosmetic | |
JP3213868B2 (en) | Pack cosmetics | |
JPS6357598A (en) | Quaternary trimethylammonium-derived casein polypeptide | |
JPH0253708A (en) | Preparation of peelable pack for smoothening wrinkle | |
JP2769341B2 (en) | Stable external base composition | |
JPS61251607A (en) | Pack cosmetic | |
JPH08290051A (en) | Hydrous gel base agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |